Avive Solutions, Inc.

Avive Solutions, Inc. emerged from a shared vision among its co-founders, Rory Beyer, Moseley Andrews, and Sameer Jafri, who united in 2017 with a compelling idea: to empower anyone to positively impact the outcome of a Sudden Cardiac Arrest (SCA) event. What began as a concept, fueled by Beyer and Andrews' technical ingenuity in developing a novel AED at MIT and Jafri's experience in SCA prevention through his non-profit, the Saving Hearts Foundation, quickly evolved into a mission-driven company. Initially operating under the name Revive Solutions, the company embarked on a journey to challenge the decades-long stagnation in SCA survival rates, which hovered around a grim 10%.

The team recognized that a fresh, more streamlined approach was desperately needed. Their early efforts focused on creating an automated external defibrillator (AED) that was not only technologically advanced but also accessible, intuitive, and affordable. This led to the development of the Avive Connect AED®, a device designed to be one of the most advanced in the industry, emphasizing portability and robust connectivity features like Cellular, Wi-Fi, GPS, and Bluetooth. This connectivity underpins Avive's innovative software solutions, aimed at creating a comprehensive cardiac arrest response system. The company secured crucial early funding, including a $7 million seed round in 2019/2020 and a significant $22 million Series A in March 2022, enabling them to advance their technology and pursue FDA approval, which was granted in October 2022. Since the successful launch of the Avive Connect AED in the summer of 2023, the company has witnessed tremendous demand and, most importantly, their devices have already been instrumental in saving numerous lives. Avive continues to innovate with features like QuickRescue™, which allows real-time data sharing with 911, and the REALConnect™ Platform for managing AED fleets, solidifying their commitment to revolutionizing SCA response and making life-saving technology ubiquitous.